Literature DB >> 8482493

Pyrazine CH- and NH-acids. Antithrombotic activity and chromatographic behaviour.

J Petrusewicz1, R Gami-Yilinkou, R Kaliszan, B Pilarski, H Foks.   

Abstract

1. A series of newly synthesized pyrazine CH- and NH-acids was subjected to analytical and pharmacological studies. 2. The compounds were chromatographed in HPLC systems employing three reversed-phase columns and methanol-buffer solvents of various composition at acidic, neutral and alkaline pH. 3. Chemometrical analysis by the principal component method allowed for ordering of the compounds on a plane determined by the first two principal component axes. 4. Pharmacological tests were done for representatives of the series of compounds. 5. An in vivo antithrombotic assay on mice proved diversified bioactivity within the group of agents. 6. Attempts were undertaken to relate chromatographic behaviour to antithrombotic activity. 7. Based on the results obtained, an approach was proposed to reduce the number of pharmacological tests in selecting the most promising agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482493     DOI: 10.1016/0306-3623(93)90005-i

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

1.  Evaluation of molecular descriptors and HPLC retention data of analgesic and anti-inflammatory drugs by factor analysis in relation to their pharmacological activity.

Authors:  Marcin Koba; Jolanta Stasiak; Leszek Bober; Tomasz Baczek
Journal:  J Mol Model       Date:  2010-02-01       Impact factor: 1.810

2.  n-Butyl 2-(3-chloro-1,2-dihydro-pyrazin-2-yl-idene)-2-cyano-acetate.

Authors:  Anita Stefańska; Tadeusz Ossowski; Lukasz Ponikiewski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-15

3.  Pyrazino[2,3-b]indolizine-10-carbonitrile.

Authors:  Anita Stefańska; Dorota Zarzeczańska; Tadeusz Ossowski; Artur Sikorski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-14

4.  2-(3-Chloro-1,2-dihydro-pyrazin-2-yl-idene)malononitrile.

Authors:  Anita Stefańska; Tadeusz Ossowski; Artur Sikorski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-02-28

5.  Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity.

Authors:  Jolanta Stasiak; Marcin Koba; Leszek Bober; Tomasz Baczek
Journal:  Int J Mol Sci       Date:  2010-07-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.